Scientific Publications

InfoMedics offers expertise in the development and publication of manuscripts, abstracts/posters, and presentations based on the data generated from our patient feedback programs. Our data have been presented at numerous well-recognized national conventions, such as the American Academy of Dermatology, the American Psychiatric Association, and the American Academy of Allergy, Asthma, and Immunology, as well as in several peer-reviewed journals.

When published, patient feedback data can help raise awareness of a specific disease state and define where your brand or brand category fits into the treatment paradigm. As importantly, these data can serve to educate the healthcare community about patients' perceptions of their disease and its treatment. As the sponsor of programs that have real impact on healthcare, your company will be recognized as a valued partner by healthcare professionals and patients alike.

2009-Present

Hamilton T, Patel N, Sumner M, Solomon D, Kerney D. Initial Results from a Patient Experience Program in Patients Receiving MMX^® Mesalazine for the Treatment of Ulcerative Colitis. Presented at the Canadian Digestive Diseases Week Annual Conference, Toronto, Ontario, Canada, February 2010.

Hamilton T, Patel N, Sumner M, Solomon D, Kerney D. Preliminary Outcomes from an MMX^® Mesalazine Patient Experience Programme in Patients with Ulcerative Colitis. Presented at the 5th Congress of the European Crohn's and Colitis Organisation, Prague, Czech Republic, February 2010.

Antonucci D, Manos M, Kerney DL, Lopez FA. Lisdexamfetamine Dimesylate as Treatment for Attention-Deficit/Hyperactivity Disorder in Children Previously Treated With Osmotic-Release Oral System-Methylphenidate: Parental Impressions. Presented at the European Psychiatric Association 18th European Congress of Psychiatry, Munich, Germany, February 2010.

Newman D, Green L. Patients' Experience with Darifenacin: Results of a Community-based Survey in Overactive Bladder Patients. Presented at the Society for Urodynamics and Female Urology Annual Meeting, St Petersburg, Florida February 2010.

Hamilton T, Patel N, Sumner M, Solomon D, Kerney D. Preliminary Outcomes from the MMX^® Mesalamine Patient Experience Program in Patients with Ulcerative Colitis. Presented at the 8th Annual Advances in Inflammatory Bowel Diseases Research Conference, Hollywood, FL, December 2009.

Babcock T, Shepski J, Manos M, Antonucci D, Kerney D. Patient Experience and Satisfaction with Lisdexamfetamine Dimesylate in Adults with Attention-Deficit/Hyperactivity Disorder Who Were Previously Treated With Mixed Amphetamine Salts Extended Release. Presented at U.S. Psychiatric & Mental Health Congress, Las Vegas, NV, November 2009.

Hamilton T, Sumner M, Solomon D, Kerney D. MMX^® Mesalamine Treatment for Ulcerative Colitis: Preliminary Outcomes from a Patient Experience Program. Presented at the Annual Meeting of the American College of Gastroenterology, San Diego, CA, October 2009.

Manos M, Kerney DL, Lopez FA, Antonucci D. Lisdexamfetamine Dimesylate Treatment for Adults With Attention-Deficit/Hyperactivity Disorder Previously Treated With Osmotic-Release Oral System-Methylphenidate: Patient Impressions. Presented at the 61st Institute for Psychiatric Services, New York, NY, October 2009.

Antonucci D, Kerney DL, Lopez FA, Manos M. Lisdexamfetamine Dimesylate as Treatment for Attention-Deficit/Hyperactivity Disorder in Adults Previously Treated With Immediate-Release Stimulants: Patient Impressions. Presented at the 61st Institute for Psychiatric Services, New York, NY, October 2009.

Hunt P, Slater J, Antonucci D, Kerney DL, Lopez FA, Manos M. Lisdexamfetamine Dimesylate as Treatment for Attention-Deficit/Hyperactivity Disorder in Children Previously Treated With Osmotic-Release Oral System-Methylphenidate: Parental Impressions. Presented at the 21st Annual International Conference on AD/HD, Cleveland, OH, October 2009.

Antonucci D, Kerney D, Lopez FA, Manos M. Patient Experience and Satisfaction With Lisdexamfetamine Dimesylate in Adults With ADHD. Presented at the 2009 Annual Meeting of the American Psychiatric Association, San Francisco, CA, May 2009.

Manos M, Antonucci D, Kerney D, DeLeon A. Patient Experience and Satisfaction With Lisdexamfetamine Dimesylate in Adults With ADHD Who Were Previously Treated With Mixed Amphetamine Salts Extended Release. Presented at the 2009 Annual Meeting of the College of Psychiatric and Neurologic Pharmacists, Jacksonville, FL, April 2009.

Kerney DL, Ford R, Gotz V. Patient Assessment of Desonide Hydrogel for the Treatment of Mild to Moderate Atopic Dermatitis. Presented at the 2009 Annual Meeting of the American Academy of Dermatology, San Francisco, CA, March 2009.

Antonucci D, Manos M, Kunins C, Lopez FA, Kerney DL. Patient Experience and Satisfaction With Lisdexamfetamine Dimesylate in Adults With ADHD. Primary Psychiatry. 2010;17(6):48-57.

Antonucci D, Kunins C, Manos M, Lopez FA, Kerney DL. Assessing Effects of Treatment With Lisdexamfetamine Dimesylate for Pediatric Attention-Deficit/Hyperactivity Disorder Using a Parental Survey. CNS Spectrums. 2010;15(4)248-256.

Antonucci D. Assessing Effects of Treatment for Pediatric ADHD Using a Parental Survey. Psychiatry Weekly. 2010;5(8).

Scientific Publications: 2006-2008

Scientific Publications: 2003-2005

Scientific Publications: 2000-2002

Scientific Publications: Full List

Scientific Publications PDF